Keep up to date with the latest news delivered direct to your Inbox.
Breast Cancer Drug Trialled In Cornwall "Unprecedented"
8:13am 29th September 2014
(Updated 8:13am 29th September 2014)
Doctors at Treliske say the results of a new breast cancer drug are "unprecedented."
Cornish patients took part in a trial of Perjeta.
It works by blocking signals that make the tumour more agressive.
Now experts say it can extend the life of women with advanced forms of the diesease by an average of almost 16 months.
Used in conjunction with Herceptin and chemotherapy scientists say it can give HER2-positive women another five years.
But the watchdog has already said it thinks it is too expensive for the NHS.
Dr Duncan Wheatley from the Royal Cornwall Hospital said: "These results are unprecedented.
"Never before in advanced breast cancer have we seen a treatment with such a huge survival benefit, let alone in this particular sub-type of breast cancer which is regarded as being difficult-to-treat with a poor prognosis.
“The strategy of combining two HER2-targeted antibodies with complementary mechanisms of action means that we can control the cancer and extend survival for significantly longer than ever before, while minimising the toxicity. This marks a significant step forward in the fight against the disease and something that should be celebrated.”
Professor David Miles, Consultant Medical Oncologist, lead the study. He said: "These results are impressive. They show a magnitude of survival benefit which we have never seen before in advanced breast cancer, let alone this particular type, previously regarded as having a poor prognosis and being difficult to treat.
“The introduction of Herceptin made a huge difference for our patients but this strategy of combining Herceptin with this second HER2-targeted antibody with complementary mechanisms, means that we are able to control the cancer and prolong survival for even longer.
"The observation that women with HER2-positive metastatic breast cancer can live alongside their disease for so many years is frankly unprecedented. These data represent a significant step forward in the fight against breast cancer with combination therapies such as this paving the way for cancer treatments in the future.”
Share This StoryTweet
Blood Cancer Drug Could Cut Patient Risk
It was trialled in Cornwall at Treliske hospital
WATCH: Consultation On Cuts For Student Transport In Cornwall
Students over 16 could be forced to pay more to get to school
WATCH: Firefighter's Death Sparks Mannequin Challenge
Cornish crews staged this video as a road safety warning
BREAKING: One Person Cut Free After Crash
It closed stretch of A30 near Bodmin, sparking long delays
WATCH: Christmas Cybercrime Warnings For Cornwall
Cornwall News: How three little words could protect thousands of us online...
'Secure schools' plan for some young offenders
National News: Some young offenders will now be held in secure schools rather than youth jails as part of a new Government plan to lower re-offending rates.
Business Cornwall News - Friday, 18th December 2015
Business Cornwall News: Cornwall is spearheading reform of the Uk’s business licensing laws following a a year-long project.
Patti Smith forgets lines while performing Bob Dylan Nobel tribute
Showbiz News: Patti Smith has given a stumbling performance of Bob Dylan's A Hard Rain's A-Gonna Fall at a gala ceremony for Nobel laureates.
Dozens dead and wounded after church roof collapses in Nigeria
World News: The roof of a church has collapsed during a packed service in Nigeria, killing at least 60 worshippers and wounding dozens of others, authorities have said.
Badminton and wheelchair rugby among sports to lose Olympic funding
Sports News: Archery, badminton, fencing, weightlifting and wheelchair rugby will not get funding in the run up to the Tokyo Olympics.
Fancy a snooze? Edinburgh University students back £10k 'nap pods' on campus
Strange News: Students at Edinburgh University have voted in favour of installing "nap pods" in an effort to beat sleep deprivation.